[ET Net News Agency, 26 June 2026] DUALITYBIO-B (09606) fell 3.3% to HK$162.6.
It hits an intra-day low of HK$162.1, hitting a historical low, and an intra-day high of HK$169.4. The total shares traded was 153,480, with a value of HK$25.31m. The active buy/sell ratio is 46:54, with net selling turnover of HK$1.8m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$1.3m, with volume weighted average price of HK$164.028. UBS accounts for greatest net responsive selling turnover of HK$1.28m, with volume weighted average price of HK$165.429. The stock has fallen a combined 12.2% over the past 5 consecutive trading days.
Basic Information| Nominal | 162.600 | % Chg | -3.27% |
| High | 169.400 | Low | 162.100 |
| Shares Tr | 153,480 | Turnover | 25.31m |
| 10-D SMA | 177.910 | %H.V | 63.446 |
| 20-D SMA | 184.985 | VWAP | 164.887 |
| 50-D SMA | 231.650 | RSI14 | 27.587 |
Status: Hitting a historical low, active buy/sell ratio is 46:54, with net selling turnover of HK$1.8m, falling a combined 12.2% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| DUALITYBIO-B (09606) | 162.60 | -3.27 |
| INNOVENT BIO (01801) | 74.40 | -2.23 |
| WUXI XDC (02268) | 56.75 | -0.18 |
| WUXI BIO (02269) | 32.72 | -1.15 |
| WUXI APPTEC (02359) | 145.00 | Unchanged |
| PHARMARON (03759) | 17.26 | +3.04 |
| BEONE MEDICINES (06160) | 166.00 | -0.60 |
| SKB BIO (06990) | 414.20 | +0.39 |
| AKESO (09926) | 82.30 | -3.69 |
| REMEGEN (09995) | 68.95 | -1.57 |
(ed)
Nominal 
